Research Projects & Grants

Non-Profit Organization

  • (Bristol/Theradex) A phase II trial of paclitaxel (taxol) administered as a weekly one hour infusion in previously treated patients with head and neck cancers, Role: Investigator, Bristol-Myers Squibb Foundation, Inc., (10/2000 - 10/2001) Status: Completed